Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan) (ESSENCE)

Viatris

Status: Completed

Conditions: Hypertension

Treatments: Drug: Selara

Study type: Observational

Funder types: Industry

Identifiers

NCT00749775

A6141113

Details and patient eligibility

About

To collect the efficacy and safety information of Eplerenone on patients with hypertension related to their appropriate use in daily practice.

Enrollment: 3,338 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or Female patients who are prescribed Selara tablet for Hypertension.

Exclusion criteria

• Subjects who have been prescribed Selara tablet.

Trial design

3,338 participants in 1 patient group

Eplerenone

Description:

Subjects who are treated with Eplerenone tablet for hypertension disease

Treatment:

Drug: Selara